01 3Dipharma Francis Srl
02 2Shandong New Time Pharmaceutical Co., Ltd.
01 1DILUTED ISOSORBIDE MONONITRATE
02 1IS5MN 70% Lactose 200 30%
03 1IS5MN 80% Lactose 200 20%
04 2ISOSORBIDE MONONITRATE
01 2China
02 3Italy
NDC Package Code : 46438-1110
Start Marketing Date : 2014-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0025
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0027
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42677-102
Start Marketing Date : 2011-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.7kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 42677-101
Start Marketing Date : 2011-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.6kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
26
PharmaCompass offers a list of Isosorbide Mononitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isosorbide Mononitrate manufacturer or Isosorbide Mononitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isosorbide Mononitrate manufacturer or Isosorbide Mononitrate supplier.
PharmaCompass also assists you with knowing the Isosorbide Mononitrate API Price utilized in the formulation of products. Isosorbide Mononitrate API Price is not always fixed or binding as the Isosorbide Mononitrate Price is obtained through a variety of data sources. The Isosorbide Mononitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Olicard-retard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olicard-retard, including repackagers and relabelers. The FDA regulates Olicard-retard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olicard-retard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olicard-retard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olicard-retard supplier is an individual or a company that provides Olicard-retard active pharmaceutical ingredient (API) or Olicard-retard finished formulations upon request. The Olicard-retard suppliers may include Olicard-retard API manufacturers, exporters, distributors and traders.
click here to find a list of Olicard-retard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olicard-retard as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olicard-retard API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olicard-retard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olicard-retard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olicard-retard NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olicard-retard suppliers with NDC on PharmaCompass.
We have 2 companies offering Olicard-retard
Get in contact with the supplier of your choice:
